Homodimers of Vanillin and Apocynin Decrease the Metastatic Potential of Human Cancer Cells by Inhibiting the FAK/PI3K/Akt Signaling Pathway. Jantaree P, Lirdprapamongkol K*, Kaewsri W, Thongsornkleeb C, Choowongkomon K, Atjanasuppat K, Ruchirawat S, Svasti J. J Agric Food Chem 2017;65(11):2299-306.

22 Mar 2017
0
0

Homodimers of Vanillin and Apocynin Decrease the Metastatic Potential of Human Cancer Cells by Inhibiting the FAK/PI3K/Akt Signaling Pathway.

Jantaree P, Lirdprapamongkol K*, Kaewsri W, Thongsornkleeb C, Choowongkomon K, Atjanasuppat K, Ruchirawat S, Svasti J.

J Agric Food Chem 2017;65(11):2299-306.

Tags

Share this

Related Posts

Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., . . . Wiltrout, R. H. (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut, 65(10), 1765-1775. doi:10.1136/gutjnl-2014-308810
01 Oct 2016
0

Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., . . . Wiltrout, R. H. (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut, 65(10), 1765-1775. doi:10.1136/gutjnl-2014-308810

Scarzello, A. J., Jiang, Q., Back, T., Dang, H., Hodge, D., Hanson, C., . . . Wiltrout, R. H. (2016). LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours. Gut, 65(10), 1765-1775. doi:10.1136/gutjnl-2014-308810
View More
Thongdee, P.; Hanwarinroj, C.; Pakamwong, B.; Kamsri, P.; Punkvang, A.; Leanpolchareanchai, J.; Ketrat, S.; Saparpakorn, P.; Hannongbua, S.; Ariyachaokun, K.; Suttisintong, K.; Sureram, S.; Kittakoop, P.; Hongmanee, P.; Chanthammachat, P.; Mukamolova, G.; Blood, R.; Takebayashi, Y.; Spencer, J.; Mulholland, A,; Pungpo, P. Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial Activity. J. Chem. Inf. Model. 2022, DOI: 10.4155/fmc-2022-0124
22 Aug 2022
0

Thongdee, P.; Hanwarinroj, C.; Pakamwong, B.; Kamsri, P.; Punkvang, A.; Leanpolchareanchai, J.; Ketrat, S.; Saparpakorn, P.; Hannongbua, S.; Ariyachaokun, K.; Suttisintong, K.; Sureram, S.; Kittakoop, P.; Hongmanee, P.; Chanthammachat, P.; Mukamolova, G.; Blood, R.; Takebayashi, Y.; Spencer, J.; Mulholland, A,; Pungpo, P. Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial Activity. J. Chem. Inf. Model. 2022, DOI: 10.4155/fmc-2022-0124

Thongdee, P.; Hanwarinroj, C.; Pakamwong, B.; Kamsri, P.; Punkvang, A.; Leanpolchareanchai, J.; Ketrat, S.; Saparpakorn, P.; Hannongbua, S.; Ariyachaokun, K.; Suttisintong, K.; Sureram, S.; Kittakoop, P.; Hongmanee, P.; Chanthammachat, P.; Mukamolova, G.; Blood, R.; Takebayashi, Y.; Spencer, J.; Mulholland, A,; Pungpo, P. Virtual Screening Identifies Novel and Potent Inhibitors of Mycobacterium tuberculosis PknB with Antibacterial Activity. J. Chem. Inf. Model. 2022, DOI: 10.4155/fmc-2022-0124
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More